Riociguat (trade name Adempas) is a drug by Bayer that is a stimulator of soluble guanylate cyclase (sGC). It is used to treat two forms of pulmonary hypertension (PH): chronic thromboembolic pulmonary hypertension (CTEPH) and pulmonary arterial hypertension (PAH). Riociguat constitutes the first drug of the class of sGC stimulators...Wikipedia
Manufacturer's Website: Adempas Average retail cost: $3,131/month
Search Terms: Adempas, riociguat, chronic thromboembolic pulmonary hypertension, CTEPH, pulmonary arterial hypertension, PAH